About this trial
The investigators are trying to study that there is no difference in improvement of motion between static progressive and dynamic splinting.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Demographic - Over 18 years of age and ambulatory without a gait aid with no history of narcotic use
Diagnosis - Unilateral or bilateral acute (< 6 months of pain) plantar fasciitis (i.e., Heel pain that increases with weightbearing, "First step pain": heel pain that occurs after a period of non-weightbearing, such as in the morning when arising from bed or when arising after prolonged sitting; the pain is improved after a few minutes walking but will worsen again with prolonged weightbearing, tenderness over the medial calcaneal tuberosity at the insertion of the plantar fasciitis)
Permitted - Icing, NSAIDS( ibuprofen), Custom Shoe Inserts, Diagnostic Ultrasound
Disqualifiers
Demographic - Under 18 year of age, requires a gait aid for ambulation; if not covered by insurance,
Diagnosis of - Arthritis of the Ankle, Midfoot, or Forefoot; Inflammatory Arthritis; Gout; Turf Toe; Hallux Rigidus; Hallux Limitus; Sesamoiditis; Tendonitis or Tendinopathy; Prior tear or Rupture of the Plantar Fascia; Fibromyalgia, Neuralgia, or Neuropathy; Peripheral Vascular Disease; Prior Trauma to the Heel, Fracture of the Calcaneus; Infection; Corn; Callus; Ingrown Nail.
Patient with history of Symptoms for over 6 months
Refractory to prior splint-based treatments
Trial design
Parallel
Treatments tested in this trial
Dynamic splint
DeviceDevice treats plantar fasciitis and replacing boot immobilization which is quite benign
Treatment groups
Trial outcomes
Primary outcomes
NO pain at 1 month follow up
We plan to use VAS pain scale as measurement scale ( range; 0-10, higher scores correspond to greater pain)
NO pain at 3 months follow up
We plan to use VAS pain scale as measurement scale ( range; 0-10, higher scores correspond to greater pain)
NO pain at 6 months follow up
We plan to use VAS pain scale as measurement scale ( range; 0-10, higher scores correspond to greater pain)
Secondary outcomes
Clinically relevant change in Foot Function Index (FFI)
Clinically relevant change in Foot Function Index (FFI) of \>6.5 points (MCID
Clinically relevant change in Foot Function Index (FFI)
Clinically relevant change in Foot Function Index (FFI) of \>6.5 points (MCID
Clinically relevant change in Foot Function Index (FFI)
Clinically relevant change in Foot Function Index (FFI) of \>6.5 points (MCID
Sponsors and contacts
Click on the lead sponsor to view all of their trials.